Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening

Martijn J Wilmer, Chee Ping Ng, Henriëtte L Lanz, Paul Vulto, Laura Suter-Dick, Roos Masereeuw

Research output: Contribution to journalReview articlepeer-review


Improved model systems to predict drug efficacy, interactions, and drug-induced kidney injury (DIKI) are crucially needed in drug development. Organ-on-a-chip technology is a suitable in vitro system because it reproduces the 3D microenvironment. A kidney-on-a-chip can mimic the structural, mechanical, transport, absorptive, and physiological properties of the human kidney. In this review we address the application of state-of-the-art microfluidic culturing techniques, with a focus on culturing kidney proximal tubules, that are promising for the detection of biomarkers that predict drug interactions and DIKI. We also discuss high-throughput screening and the challenges for in vitro to in vivo extrapolation (IVIVE) that will need to be overcome for successful implementation.

Original languageEnglish
Pages (from-to)156-170
JournalTrends in Biotechnology
Issue number2
Publication statusPublished - 2016


Dive into the research topics of 'Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening'. Together they form a unique fingerprint.

Cite this